TransMedics Group, Inc.

NASDAQ:TMDX

74.57 (USD) • At close February 5, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q1
Revenue 108.761114.30596.8581.17466.4352.46541.55431.37525.68320.52115.889.6685.378.1717.0537.6277.0913.3917.536.0577.2055.6664.6763.5444.0392.9152.5192.1061.8672.2321.856
Cost of Revenue 47.91645.14436.98833.2525.76815.72412.78810.6727.5686.1713.7762.6821.5972.5822.2422.7992.0531.4822.672.3162.9892.3332.1032.0451.9071.7361.5951.5771.3821.4211.295
Gross Profit 60.84569.16159.86247.92440.66236.74128.76620.70318.11514.3512.1046.9863.7735.5894.8114.8285.0381.9094.863.7414.2163.3332.5731.4992.1321.1790.9240.5290.4850.8110.562
Gross Profit Ratio 0.5590.6050.6180.590.6120.70.6920.660.7050.6990.7620.7230.7030.6840.6820.6330.710.5630.6450.6180.5850.5880.550.4230.5280.4040.3670.2510.260.3630.303
Reseach & Development Expenses 14.26613.85811.3810.76138.3448.2915.8715.7566.8086.7147.5346.3145.1636.2954.5324.5484.1553.9036.2256.2624.9394.7873.8823.4863.2723.4333.4653.4023.4024.1934.077
General & Administrative Expenses 042.89536.16134.5630.65327.93824.9843.51716.85116.19413.9391210.3359.1626.7866.1765.4935.8676.6526.1736.5196.2514.6534.3742.7992.9022.240000
Selling & Marketing Expenses 0-0.1-0.1-1.41801.418018.20901.1870-0.188000.1880.3650.07900.48700.3270.6410.5070.230.0950.3870.3110000
SG&A 42.65642.79536.06134.5630.65329.35624.98421.72616.85117.38113.9391210.3359.1626.7866.1765.4935.8676.6526.1736.5196.2514.6534.3742.7992.9022.241.6331.8122.332.08
Other Expenses 003.57-7.9354.9962.4310.5551.085-1.076-0.784-0.227-0.345-0.2490.171-0.4540.5660.4990.3710.2170.590.0560.247-0.103-0.0610.101-0.4280.1750000
Operating Expenses 56.92256.65347.44145.32168.99737.64730.85527.48223.65924.09521.47318.31415.49815.45711.31810.7249.6489.7712.87712.43511.45811.0388.5357.866.0716.3355.7055.0055.1126.2776.02
Operating Income 3.92312.50812.4212.603-28.335-0.906-2.089-6.779-5.544-9.745-9.369-11.328-11.725-9.868-6.507-5.896-4.61-7.861-8.017-8.694-7.242-7.705-5.962-6.361-3.939-5.156-4.781-4.506-4.729-5.712-5.596
Operating Income Ratio 0.0360.1090.1280.032-0.427-0.017-0.05-0.216-0.216-0.475-0.59-1.172-2.183-1.208-0.923-0.773-0.65-2.318-1.065-1.435-1.005-1.36-1.275-1.795-0.975-1.769-1.898-2.14-2.533-2.559-3.015
Total Other Income Expenses Net 0.322-0.355-0.0281.261.406-0.074-0.5360.078-1.863-1.756-1.187-1.323-1.228-0.794-1.406-0.405-0.472-0.63-0.825-0.473-1.028-1.48-0.923-1.256-1.158-0.951-0.113-0.138-0.068-0.023-0.021
Income Before Tax 4.24512.15312.3933.863-26.929-0.98-2.625-6.701-7.407-11.501-10.556-12.651-12.953-10.662-7.913-6.301-5.082-8.491-8.842-9.167-8.27-9.185-6.885-7.617-5.097-6.107-4.894-4.644-4.797-5.735-5.675
Income Before Tax Ratio 0.0390.1060.1280.048-0.405-0.019-0.063-0.214-0.288-0.56-0.665-1.309-2.412-1.305-1.122-0.826-0.717-2.504-1.174-1.513-1.148-1.621-1.472-2.149-1.262-2.095-1.943-2.205-2.569-2.569-3.058
Income Tax Expense 0.029-0.0410.196-0.168-1.5070.0210.0110.0190.0190.0220.0060.0170.0090.0060.0040.010.0060.0060.010.010.010.010.010.0180.0080.0080.0070.0040.0090.0090.01
Net Income 4.21612.19412.1974.031-25.422-1.001-2.636-6.72-7.426-11.523-10.562-12.668-12.962-10.668-7.917-6.311-5.088-8.497-8.852-9.177-8.28-9.195-6.895-7.635-5.105-6.115-4.901-4.648-4.806-5.744-5.685
Net Income Ratio 0.0390.1070.1260.05-0.383-0.019-0.063-0.214-0.289-0.562-0.665-1.31-2.414-1.306-1.123-0.827-0.718-2.506-1.176-1.515-1.149-1.623-1.475-2.154-1.264-2.098-1.946-2.207-2.574-2.573-3.063
EPS 0.130.370.370.12-0.78-0.031-0.082-0.21-0.25-0.41-0.38-0.46-0.47-0.39-0.29-0.23-0.19-0.36-0.42-0.43-0.39-0.7-0.36-0.4-0.35-0.42-0.34-1-1.03-1.24-1.22
EPS Diluted 0.120.350.350.12-0.78-0.031-0.082-0.21-0.25-0.41-0.38-0.46-0.47-0.39-0.29-0.23-0.19-0.36-0.42-0.43-0.39-0.7-0.36-0.4-0.35-0.42-0.34-1-1.03-1.24-1.22
EBITDA 13.03917.10716.82311.173-21.4463.149-0.056-4.224-5.549-9.745-8.911-10.378-11.519-9.246-6.516-4.9-3.709-7.116-7.429-7.748-6.854-7.783-5.547-6.325-3.808-5.79-4.615-4.337-4.554-5.569-5.453
EBITDA Ratio 0.120.150.1740.078-0.3510.029-0.037-0.181-0.223-0.474-0.572-1.207-2.145-1.132-0.987-0.699-0.58-2.209-0.987-1.338-0.997-1.265-1.297-1.75-0.897-1.857-1.763-2.059-2.439-2.495-2.938